These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 37409482)

  • 1. Extracellular Vesicle-Encapsulated Adeno-Associated Viruses for Therapeutic Gene Delivery to the Heart.
    Li X; La Salvia S; Liang Y; Adamiak M; Kohlbrenner E; Jeong D; Chepurko E; Ceholski D; Lopez-Gordo E; Yoon S; Mathiyalagan P; Agarwal N; Jha D; Lodha S; Daaboul G; Phan A; Raisinghani N; Zhang S; Zangi L; Gonzalez-Kozlova E; Dubois N; Dogra N; Hajjar RJ; Sahoo S
    Circulation; 2023 Aug; 148(5):405-425. PubMed ID: 37409482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Medium-Sized Extracellular Vesicles on the Transduction Efficiency of Adeno-Associated Viruses in Neuronal and Primary Astrocyte Cell Cultures.
    Kovács OT; Soltész-Katona E; Marton N; Baricza E; Hunyady L; Turu G; Nagy G
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Golgi Calcium ATPase Pump Plays an Essential Role in Adeno-associated Virus Trafficking and Transduction.
    Madigan VJ; Berry GE; Tyson TO; Nardone-White D; Ark J; Elmore ZC; Murlidharan G; Vincent HA; Asokan A
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.
    Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC
    Elife; 2021 Oct; 10():. PubMed ID: 34664552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preexisting Neutralizing Antibodies against Different Adeno-Associated Virus Serotypes in Humans and Large Animal Models for Gene Therapy.
    Ail D; Dalkara D
    Adv Exp Med Biol; 2023; 1415():117-123. PubMed ID: 37440023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using an In Vivo Mouse Model to Determine the Exclusion Criteria of Preexisting Anti-AAV9 Neutralizing Antibody Titer of Pompe Disease Patients in Clinical Trials.
    Wang H; Zhang C; Dong Z; Zhu X; Zheng X; Liu Z; Zhou J; Yu S; Wu X; Dong X
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo.
    György B; Fitzpatrick Z; Crommentuijn MH; Mu D; Maguire CA
    Biomaterials; 2014 Aug; 35(26):7598-609. PubMed ID: 24917028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure.
    Greenberg B; Butler J; Felker GM; Ponikowski P; Voors AA; Pogoda JM; Provost R; Guerrero J; Hajjar RJ; Zsebo KM
    Gene Ther; 2016 Mar; 23(3):313-9. PubMed ID: 26699914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing Antibody Evasion and Transduction with Purified Extracellular Vesicle-Enveloped Adeno-Associated Virus Vectors.
    Cheng M; Dietz L; Gong Y; Eichler F; Nammour J; Ng C; Grimm D; Maguire CA
    Hum Gene Ther; 2021 Dec; 32(23-24):1457-1470. PubMed ID: 34445894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Seroprevalence of Neutralizing Antibodies Targeting Two Clade F AAV in Humans.
    Ellsworth JL; O'Callaghan M; Rubin H; Seymour A
    Hum Gene Ther Clin Dev; 2018 Mar; 29(1):60-67. PubMed ID: 29624457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput
    Westhaus A; Cabanes-Creus M; Rybicki A; Baltazar G; Navarro RG; Zhu E; Drouyer M; Knight M; Albu RF; Ng BH; Kalajdzic P; Kwiatek M; Hsu K; Santilli G; Gold W; Kramer B; Gonzalez-Cordero A; Thrasher AJ; Alexander IE; Lisowski L
    Hum Gene Ther; 2020 May; 31(9-10):575-589. PubMed ID: 32000541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV Vectors for Efficient Gene Delivery to Rodent Hearts.
    Lopez-Gordo E; Kohlbrenner E; Katz MG; Weber T
    Methods Mol Biol; 2019; 1950():311-332. PubMed ID: 30783983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
    Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
    Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing antibodies to candidate gene therapy vectors (adeno-associated vector serotypes) in domestic cats.
    Li P; Boenzli E; Hofmann-Lehmann R; Helfer-Hungerbuehler AK
    PLoS One; 2019; 14(3):e0212811. PubMed ID: 30897117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful liver transduction by re-administration of different adeno-associated virus vector serotypes in mice.
    Baatartsogt N; Kashiwakura Y; Hiramoto T; Hayakawa M; Kamoshita N; Ohmori T
    J Gene Med; 2023 Aug; 25(8):e3505. PubMed ID: 36972408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of adeno-associated virus serotypes for gene transfer in organotypic heart slices.
    Liu Z; Klose K; Neuber S; Jiang M; Gossen M; Stamm C
    J Transl Med; 2020 Nov; 18(1):437. PubMed ID: 33208161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay.
    Bass-Stringer S; Thomas CJ; May CN; Gregorevic P; Weeks KL; McMullen JR
    J Vis Exp; 2021 Dec; (178):. PubMed ID: 34958085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling.
    Miyazaki Y; Ikeda Y; Shiraishi K; Fujimoto SN; Aoyama H; Yoshimura K; Inui M; Hoshijima M; Kasahara H; Aoki H; Matsuzaki M
    PLoS One; 2012; 7(4):e35875. PubMed ID: 22558250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-Associated Virus Mediated Gene Delivery: Implications for Scalable
    Ambrosi CM; Sadananda G; Han JL; Entcheva E
    Front Physiol; 2019; 10():168. PubMed ID: 30890951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors.
    García-Olloqui P; Rodriguez-Madoz JR; Di Scala M; Abizanda G; Vales Á; Olagüe C; Iglesias-García O; Larequi E; Aguado-Alvaro LP; Ruiz-Villalba A; Prosper F; Gonzalez-Aseguinolaza G; Pelacho B
    J Tissue Eng Regen Med; 2020 Jan; 14(1):123-134. PubMed ID: 31677236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.